Diabetes Clinic
218 Percy St.
Smiths Falls, ON
K7A 4W8

Telephone: (613) 284-0145
Fax: (613) 283-9020
Toll Free: 1-800-717-0145
Email: diabetes@diabetesclinic.ca

Ontario Medical Assoc


Canadian Medical Association


American Diabetes Association


Canadian Diabetes Association; Executive of the Clinical & Scientific Section, Associate Editor Canadian Diabetes


Canadian Society of Endocrinology & Metabolism


European Association for the Study of Diabetes


International Diabetes Federation


Ontario Coroners Association


Canadian Association of Aviation Medical Examiners 

Perth & Smiths Falls Community Hospitals (Active Staff)


Sault Area Hospitals (Consultant Staff)

Intensive Management of Diabetes


Insulin Pumps


Clinical Research


Medical Education of Family Practitioners 


Educational Web Site (www.diabetesclinic.ca)

• DECIDE (Pfizer), follow up of subjects exposed to inhaled insulin
• LEADER EX-2211-3748 Phase 3, CV Benefit of Liraglutide
• OpT2Mize, Phase 3, Insulin pumps in patients with Type 2 Diabetes
• Lilly Cardiovascular Events with a weekly Incretin (Dulaglutide) REWIND 2011-2013
• DECLARE-TIMI 58, Phase 3, Dapaglifozin effects on Cardiovascular Events , 2013
• EUCLID, Phase 3b study comparing Ticagrelor with Clopidogrel on CV risk in people with PAD 2013
• Merck 3102-018. Phase 3 Study. Once weekly DPP-4 Inhibitor 2013
• NN9535-3744 SUSTAIN Trial. CV Outcomes with Semaglutide, a once weekly GLP-1 Agonist
• Cardiovascular Inflammation Reduction Trial (CIRT) low dose Methotrexate to reduce cardiovascular events
• SPRINT Atrial Fibrillation (observational trial)
• Mozaic observational study on effects of long term & mixed insulins

Publications:

• E Coli H-157 in Nursing Home Patients: J Inf Dis 1992
• The Case of the Exploding Cop: Diabetes Monitor 1998 (2)305
• Rosiglitazone in Family Practice: Diabetes, June 2001, Suppl
  
• Insulin Resistance in Diabetes Mellitus, Medical Post, Nov 2001, Suppl
• Rosiglitazone in Family Practice, Cdn J Diabetes Care, meeting suppl, Oct 2001 (abstract)
• Option or Essential Tool? Insulin Pump Therapy in Young Women: Diabetes, June 2002, Suppl
• Guidelines, Do They Make a Difference? Canadian Journal of Diabetes. 2002;26(suppl):256.
• Community Based Insulin Pump Program Outcomes. Canadian Journal of Diabetes. 2002;26(suppl);272.
• Pioglitazone in Family Practice. Canadian Journal of Diabetes. 2002;26(suppl);308.
• Rosiglitazone in Family Practice. Canadian Journal of Diabetes. 2002;26 (suppl);308
  
• ,i>A Community Based Insulin Pump Program.
Diabetes. 2003;52 (Suppl 1) A518 Abstract 2246-PO
• Effectiveness of Rosiglitazone in Family Practice in Canada. Diabetes & Metabolism 2003,29,4S246, Abstract 2274
• Practical Application of Rosiglitazone in Clinical Practice. Diabetes & Metabolism 2003,29,4S246, Abstract 22772
• The Treat-to-Target Trial: Randomized Addition of Glargine or Human NPH Insulin to Oral Therapy of Type 2 Diabetic Patients. Riddle M et al. Diabetes Care. 2003;26:3080-3086.
• 2003 CDA Clinical Practice Guidelines, are they achievable. Canadian Journal of Diabetes 2003 Sept (Abstract)
• New Issues in the Management of Hypertension. Medical Post 2003, Suppl
• Type 2 Diabetes, A Family Physicians Guide, 2004
• Practical Application of Rosiglitazone in Clinical Practice. Diabetes 2004 June, Vol 53, Suppl 1 A121 (Abstract)
• Diabetes Flow Sheet with Feedback to Improve CPG Compliance. Canadian Journal of Diabetes. 2004 Sep, Vol 28 No 3, P 314
• Peri-Op & Peri-ACS Glucose Control. Canadian Diabetes, 18(2),Summer 2005 (Editorial)
• Type 2 Diabetes, A Health Professional's Guide, 2006
• Sexual Dysfunction in Diabetes. Canadian Diabetes. 19(1), Spring 2006 (Editorial)
• A Randomized Trial of Adding Insulin Glargine vs avoidance of Insulin in People with Type 2 Diabetes on either no oral glucose lowering agents or submaximal doses of Metformin and/or Sulphonylureas. The Canadian INSIGHT Study. Diabetic Medicine. 2006;
• Hypertension & Diabetic Retinopathy. Medical Post. 20 June 2006, Suppl
• Effect of Rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomized controlled trial. Lancet online Sept 15 2006. DOI:10.1016/S0140-6736(06)69420-8
• Aggressive Cardiovascular Treatment Needed for People with Diabetes. Canadian Diabetes Vol 19, No 3, 2006 (Editorial)
• Necessite d'un traitment cardio-vasculaire energique en presence de diabete. Canadian Diabetes Vol 19, No 3, 2006 (Ed)
• Advances in management options for insulin-dependent patients. The Medical Post. 12 June 2007; 43(21):(center-fold)
• Diabetes & Periodontal Disease, Canadian Dental Journal, Mar 2008
• Effects of Ramipril and/or Rosiglitazone on Cardiovascular & Renal Outcomes in People with Impaired Glucose Tolerance or Impaired Fasting Glucose. Diabetes Care. 2008, Vol 30 No 5, May 2008, 1007-1014
• Clinical Focus: Pharmacologic Management of Type 2 Diabetes. Medical Post, Supplement May 2008
• Enhancing Diabetes Care in Family Practice. Can Fam Phys. 54(9), 1237-1238, Sept 2008
• Rosiglitazone in Canada. Expert Opin Drug Metab. Toxicology. 2009;5;(4):441-448
• Is Tight Glycemic Control in T2DM Really Worthwhile? Can Fam Phys 2009: 55; 580-582
• Vaut-il vraiment la peine d’exercer un strict controle glycemique pour le diabete de type 2? Can Fam Phys 2009 : 55 ;584-586
• Casting the Net Further. Diabetes & Risk Reduction. Canadian Diabetes, Vol 23 No 2, Summer 2010-12-17
• Diabetes, Periodontal & Cardiovascular Disease. Canadian Diabetes, Vol 23 No 2, Summer 2010-12-17
• Targeted Diabetes Therapy, Canadian Diabetes, Vol 22, No 3, Winter 2010
• Long Term Effect of Rosiglitazone and/or Ramipril on the Incidence of Diabetes. Diabetologia (2011) 54 :487-495
• Dose-Dependant Antihypertensive Efficacy and Tolerability of Perindopril in a Large, Observational, 12-Week, General Practice Based Sudy (CONFIDENCE STUDY) Am J Cardiovascular Drugs 2011 ;11(1) :45-55
• Liraglutide and insulin: concomitant administration of a GLP-1 agonist with insulin and effects on A1c, insulin dose, weight, fasting blood sugar, and blood pressure. Can J Diab, 2011 September
• Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials. Zinman B, De Vries H, Bode B et al on behalf of the NN1250-3724 (BEGIN:EASY AM) and NN1250-3718 (BEGIN:EASY PM) Trial Investigators. Lancet Diabetes & Endocrinology, 29 July 2013
• Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes, (Examine Study) September 2, 2013DOI: 10.1056/NEJMoa1305889
• Saxagliptin & Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus (SAVOR TIMI-53) NEJM 2 Sept 2013 (published online)

Presentations: (Recent)

• Insulin Pump Therapy in Young Women: ADA June 2002, San Francisco
• Community Based Insulin Pump Outcomes: CDA Oct 2002, Vancouver
• Pioglitazone in Family Practice: CDA Oct 2002, Vancouver
• Rosiglitazone in Family Practice: CDA Oct 2002, Vancouver
• Guidelines, Do They Make a Difference: CDA Oct 2002, Vancouver
• A Community Based Insulin Pump Program: ADA June 2003, New Orleans
• Application of Rosiglitazone In Clinical Practice: IDF 2003, Paris, France
• 2003 CDA Clinical Practice Guidelines, are they achievable: CDA 2003, Ottawa
• Rosiglitazone in Clinical Practice, ADA June 2003
• Diabetes Flow Sheet. CDA, Oct 2004, Quebec City
• CPG Guidelines, CDA, Oct 2004, Quebec City, Satellite Symposium
• Review of Insulin Pump Therapy, NDHN May 05, Cleveland’s House
• Diabetes Flow Sheet with Feedback to enhance Guideline Compliance. CDA Edmonton 2005
• Diabetes Flow Sheet with feedback, enhancing diabetes care in family practice, CDA Toronto, Oct 2006
• Rosiglitazone in Clinical Practice, 6 years experience, International Diabetes Federation, Capetown, Dec 2006
• Perioperative Glucose Control in the Diabetic Patient having Bariatric Surdery. Advanced Diabetes Technology, Athens 2009
• SOLVE Study, Levemir & Insulin Initiation, presented at CDA Edmonton, 2010
• Liraglutide with insulin in people with Diabetes, presented at CDA, Toronto 2011

Continuing Medical Education: (Recent)

• American Diabetes Assoc, Advanced Postgraduate Course, Jan 2001
• American Diabetes Assoc. June 2003
• European Assoc for the study of Diabetes, Budapest Sept 2002
• Canadian Diabetes Assoc. Oct 2003
• International Diabetes Federation; Paris Aug 2003
• American Diabetes Assoc, June 2004
• Canadian Diabetes Assoc, Canadian Soc of Endocrinology & Metabolism, Oct 2004
• American Diabetes Assoc Annual Meeting. San Diego June 2005
• Canadian Diabetes Assoc, Canadian Soc of Endocrinology & Metabolism, Oct 2005
• American Diabetes Assoc Annual Meeting Washington June 2006
• European Assoc for the Study of Diabetes, Copenhagen, Sept 2006
• Canadian Diabetes Assoc, Canadian Soc of Endocrinology & Metabolism, Oct 2006
• International Diabetes Federation, Capetown, Dec 2006
• International Diabetes Federation, Capetown, Dec 2006
• American Diabetes Assoc, Chicago, June 2007
• European Assoc for the Study of Diabetes, Amsterdam, Sept 2007
• Canadian Diabetes Assoc, Vancouver, Oct 2007
• American Diabetes Assoc Annual Meeting, San Francisco, June 2008
• European Assoc for the Study of Diabetes, Rome, Sept 2008
• Canadian Diabetes Assoc/CSEM, Montreal Oct 2008
• Advanced Diabetes Technologies, Athens Greece, Feb 2009
• ACLS Recertification May 2009
• American Diabetes Assoc Annual Meeting. New Orleans, June 2009
• European Assoc for the Study of Diabetes, Stockholm, Sept 2010
• Canadian Diabetes Assoc, Edmonton, Oct 2010
• American Diabetes Assoc. San Diego, June 2011
• European Assoc for the Study of Diabetes, Lisbon, Sept 2011
• Canadian Diabetes Assoc/CSEM, Toronto Oct 2011
• American Diabetes Assoc. Philadelphia, June 2012
• European Assoc for the Study of Diabetes, Berlin, Sept 2012
• Canadian Diabetes Assoc/CSEM, Vancouver Oct 2012
• American Diabetes Assoc.Chicago, June 2013
• European Assoc for the Study of Diabetes, Barcelona, Sept 2013
• Canadian Diabetes Assoc/CSEMCCS, Vascular Summit, Montrealr Oct 2013

Other Skills & Personal Interests:

• Associate Editor, Canadian Diabetes, 2006-
• Associate Editor, Canadian Journal of Diabetes, 2011-
• Guidelines Dissemination Committeae, Cnadian Diabetes Assoc, 2008- 2012
• Canadian Diabetes Assoc, Clinical & Scientific Section Executive, 2008-
• Diabetes Advisory Committee, Canadian Pharmacists Association, 2008-2009
• Research Director, Canadian Centre for Research on Diabetes 2006-
• Computers in Medicine
• Diabetes Education Web Site www.diabetesclinic.ca
• Pilot & Aircraft Owner, multi engine, instrument rating, float rating,
• Helicopter & Fixed Wing Commercial Licenses
• Ski Patroller, Mont Tremblant, Que 1987-2014
• Sailing, White Water Kayaking & Canoeing
• Military Service, Canadian Forces, Capt; Rhodesia Defense Force, Major